MUVONs CEO Deana Mohr had the great honor to present MUVONs technology and visions to Prof. Shinya Yamanaka before his public lecture at the University of Zurich on Friday, 16.09.2022.
Founder and Director Emeritus of the Center for iPS Cell Research and Applications at Kyoto University (Japan), Prof. Yamanaka can be called the godfather of iPSCs. MUVON Therapeutics and Prof. Yamanaka share the goal to bring personalized medicine solutions to patients in need.
During his lecture, Prof. Yamanaka talked about what has been achieved with iPSC-based therapies and clinical applications in the recent years. He also presented his exciting vision for the next years: “Science is advancing at an unseen pace. Our job now is to inform and prepare the society for these new developments”.
Dr. Mohr couldn´t agree more: “Being at the start of our Phase II clinical trial, I see also that patient and society education on the power of cell and gene therapies is of utmost importance.”
Prof. Yamanaka received the Nobel Prize in Physiology or Medicine in 2012 for the discovery of a phenomenon that resulted in his ground-breaking research in induced pluripotent stem cells (iPSC). iPSCs are derived from adult cells and reprogrammed to behave like embryonic stem cells, circumventing the need to harvest stem cells from embryos. With their ability to differentiate into all types of cells iPSCs are a powerful tool to model disease and investigate personalized cell therapy treatments.